Use of histone deacetylase inhibitors (HDACis) in pancreatic ductal adenocarcinoma (PDAC): A narrative review
Authors
Vassiliki Tarara
Laboratory of Histology and Embryology, Aristotle University of Thessaloniki, School of Medicine, Thessaloniki, Greece
Evangelos Karamitrousis
Medical Oncology Department, School of Medicine, Aristotle University of Thessaloniki, Papageorgiou General Hospital, Thessaloniki, Greece
Language: English
Submitted on: Oct 6, 2024
Accepted on: Dec 23, 2024
Published on: Jul 12, 2025
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Related subjects:
© 2025 Vassiliki Tarara, Evangelos Karamitrousis, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.